e-z cinnamic acid has been researched along with oxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falb, E; Hedvati, L; Kraiz, B; Nudelman, A; Sprecher, M; Zhuk, R | 1 |
| Fan, Y; Gao, C; Ge, Z; Gong, W; He, S; Huang, X; Shan, L; Tong, Y; Wang, Y; Yang, M | 1 |
2 other study(ies) available for e-z cinnamic acid and oxazoles
| Article | Year |
|---|---|
Cinnamic acid derived oxazolinium ions as novel cytotoxic agents.
Topics: Antineoplastic Agents; Cell Division; Cinnamates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Oxazoles; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Topics: Animals; Animals, Inbred Strains; Antineoplastic Agents; Biological Availability; Cinnamates; Citric Acid; Dogs; Drug Compounding; Drugs, Investigational; Excipients; Fumarates; Hydrogen-Ion Concentration; Imidazoles; Male; Nitriles; Oxazoles; Povidone; Prostatic Neoplasms; Random Allocation; Solubility; Succinic Acid; Suspensions; Tablets; Thiohydantoins | 2014 |